Testosterone replacement therapy and prostate cancer: A word of caution

被引：19
|
作者：
Brand T.C. [1 ]
Canby-Hagino E. [1 ]
Thompson I.M. [1 ]
机构：
[1] Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229
来源：
Current Urology Reports | 2007年 / 8卷 / 3期
关键词：
Prostate Cancer; Testosterone; Digital Rectal Examination; Free Testosterone; Prostatic Intraepithelial Neoplasia;
D O I：
10.1007/s11934-007-0004-x
中图分类号：
学科分类号：
摘要：
The number of men for whom testosterone is prescribed is rapidly Increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man. Copyright © 2007 by Current Medicine Croup LLC.
引用
收藏
页码：185 / 189
页数：4
相关论文
共 50 条
  • [21] Testosterone replacement therapy in the setting of prostate cancer treated with radiation
    A W Pastuszak
    A M Pearlman
    G Godoy
    B J Miles
    L I Lipshultz
    M Khera
    International Journal of Impotence Research, 2013, 25 : 24 - 28
  • [22] Testosterone replacement therapy in the setting of prostate cancer treated with radiation
    Pastuszak, A. W.
    Pearlman, A. M.
    Godoy, G.
    Miles, B. J.
    Lipshultz, L. I.
    Khera, M.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2013, 25 (01) : 24 - 28
  • [23] Prostate Cancer and Testosterone Replacement Therapy-What is the Risk?
    Carson, Culley C., III
    Kirby, Roger
    JOURNAL OF UROLOGY, 2015, 194 (06): : 1527 - 1528
  • [24] Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    A Barqawi
    E D Crawford
    International Journal of Impotence Research, 2006, 18 : 323 - 328
  • [25] Testosterone replacement therapy and the risk of prostate cancer: a perspective view
    A B Barqawi
    E D Crawford
    International Journal of Impotence Research, 2005, 17 : 462 - 463
  • [26] Testosterone replacement therapy in hypogonadal men and prostate cancer risk
    Kirby, R
    Gould, D
    BJU INTERNATIONAL, 2005, 96 (04) : 471 - 472
  • [27] Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
    Loeb, Stacy
    Folkvaljon, Yasin
    Damber, Jan-Erik
    Alukal, Joseph
    Lambe, Mats
    Stattin, Paer
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (13) : 1430 - +
  • [28] Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    Barqawi, A.
    Crawford, E. D.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2006, 18 (04) : 323 - 328
  • [29] Testosterone replacement therapy after primary treatment for prostate cancer
    Agarwal, PK
    Oefelein, MG
    JOURNAL OF UROLOGY, 2005, 173 (02): : 533 - 536
  • [30] Testosterone Replacement Therapy and Prostate Health
    A. Scott Polackwich
    Kevin A. Ostrowski
    Jason C. Hedges
    Current Urology Reports, 2012, 13 : 441 - 446
12345